Oncology experts from leading cancer organizations from around the country, including the John Theurer Cancer Center, MD Anderson Cancer Center, the Mayo Clinic, Dana Farber Cancer Institute and the National Cancer Institute, will discuss trends in patient care, novel therapies through clinical trials and emerging concepts in the management of hematological malignancies. Key topics include [...]

Oculus Innovative Sciences, Inc. (Nasdaq OCLS), a healthcare company that develops, manufactures and markets a family of products based upon the Microcyn® Technology platform, announced that preliminary results from its U.S. 40patient feasibility study, in which an enhanced formulation of the companys Microcyn Technologybased hydrogel was used in the treatment of acne, are highly encouraging [...]

Merck Sharp & Dohme Limited (MSD) welcomes the publication of the guideline for type 2 diabetes newer agents1 from the National Institute for Health and Clinical Excellence (NICE) in the UK, which recommends considering a range of newer therapy options, including Januvia (sitagliptin). The guideline recommends that the DPP4 inhibitor class, which includes sitagliptin, [...]